STUDresearch · Non-peptide
Taurine
Also known as
L-taurine · 2-aminoethanesulfonic acid · tauric acid (historical name in some older texts) · 2-aminoethane-1-sulfonic acid · Tau (abbreviation in papers)
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Systemic — a free amino sulfonic acid discussed for muscle, heart, brain and bile-acid functions; not a site-specific injection.
Capsule and powder amounts in supplement and longevity threads.
Often linked to translations of mouse studies—not a proven human lifespan dose.
Exercise-study amounts, separate from daily longevity totals. DIY pre-workout discussion often uses ~1–2 g.
Half-life & effect duration
- Half-life in the body
- Oral capsule studyAbout 1 hour; study range 0.7–1.4 hours
- Felt duration people report
- One calm accountAbout 3–4 hours
- Other accountsNext-morning drowsiness or feeling too wired to sleep
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
About 1 hour in one small oral-capsule study.
That is the extra taurine in plasma after a dose, not whole-body tissue stores or how long calm or exercise effects last.
Mean 1.0 ± 0.3 h; individual 0.7–1.4 h. Baseline concentrations were subtracted; plasma returned toward baseline over 6–8 h. Authors questioned fasting adherence for two men. Not an estimate for every form, tissue or repeated-use pattern.
- Ghandforoush-Sattari et al. (2010): oral taurine pharmacokinetics (opens in a new tab)Methods page 2, Table 2 page 3 and Discussion pages 3–4: eight men, baseline subtraction, half-life and return toward baseline; fasting uncertainty.Original methods, table, results and discussion reviewed. Small single oral-capsule study; plasma, not tissue washout or felt effects.
Felt duration people report
One person reports 3–4 hours of calm. Others describe next-morning drowsiness or feeling too wired to sleep.
The positive account was initially only two days into use; later follow-up mentions other supplements. These are different experiences, not a standard effect window.
The 30-minute figure is onset, not duration. No product identity or causal effect verified. Health context and later co-use limit attribution; commenters' GABA explanations and dosing advice are not adopted.
- Taurine?!!! — individual calm report and follow-up (opens in a new tab)May 13, 2022 OP: 30-minute onset and 3–4-hour duration. Follow-up after about a month and a half discloses nighttime supplements.Deleted-name account, initially two days, pre-existing symptoms and later co-use. No prevalence, proven treatment or guaranteed duration inferred.
- Taurine: next-day drowsiness and bedtime stimulation (opens in a new tab)Strange_Da describes next-morning drowsiness/headache. Technical-Salad-2118 describes being wired/anxious and unable to sleep.Actual comments reviewed; unverified accounts. Mechanistic guesses and directions for changing amounts not adopted.
What people say
- Human dose-equivalent talk: Authors and secondary coverage map those mouse arms to roughly ~3–6 g/day oral for an adult human — the range longevity threads most often cite, not a proven human lifespan dose. forum
- Cramps / cell fluid talk: Athletes stack taurine with magnesium and potassium for hard training, heat, or peak-week cramps; osmolyte and electrolyte-handling narratives are common, hard to isolate from the stack. forum
- Energy-drink performance: Real-world cans often deliver ~1 g taurine plus caffeine (± sugar); any “feel” is heavily confounded by caffeine and carbs. forum
- Recovery logs: Some users report less next-day soreness or easier hard sessions on multi-gram daily — anecdotal and often stacked. anecdote
- Calm / sleep minority: Evening calm or mild GABA-adjacent wind-down appears in a minority of logs; many notice nothing subjective. anecdote
- Skepticism (honest): Small ergogenic effect sizes, energy-drink confounds, biomarker reverse-findings, and missing multi-year healthy-aging RCTs keep taurine a “cheap staple experiment,” not a miracle drug. forum
- Mouse lifespan (Singh et al., Science 2023): Oral taurine from mid-life (~1000 mg/kg BW/day in key arms) raised median lifespan ~12% in female and ~10% in male mice; healthspan markers (muscle, bone, glucose tolerance, immune/brain readouts) also improved in treated animals. animal
- Monkey / worm healthspan: Same 2023 program reported healthspan-related improvements in monkeys and lifespan effects in worms; human translation still open. animal
- Human longevity proof: Cohort links between higher taurine status and healthier aging markers exist, but supplement-driven lifespan extension in people is not established; authors called for RCTs. trial
- Aging-biomarker skepticism (Fernandez et al., Science 2025): Circulating taurine did not reliably fall with age across large longitudinal human cohorts plus monkeys/mice; inter-individual variation dominated — undercuts “everyone’s levels crash so supplement” marketing. trial
- Exercise performance (acute): Meta-analytic and trial summaries report a small performance benefit from a single pre-exercise oral dose in the ~1–6 g band vs placebo (low-to-moderate certainty; endpoints and sports vary). trial
- Pre-workout timing lore: Many performance write-ups favor ~60 minutes before training to ride the plasma peak window; chronic daily loading is not always required for acute-session designs. trial
- Endurance vs strength dose chatter: Dose-response reviews note multi-gram endurance protocols (including multi-dose daily examples such as ~1 g × 5 in selected damage-prevention literature) vs much lower or mixed strength protocols — heterogeneous, not one universal gym script. trial
- Lactate / lipid-metabolism endpoints: Acute ~1 g has been linked to lower lactate in some designs; higher acute (~6 g) has been discussed for glycerol/lipid-metabolism signals without always lowering lactate — results are protocol-dependent. trial
- Cardiometabolic meta (broad): A 34-RCT / ~1,394-participant analysis covering ~0.5–6 g/day reported improvements across several cardiometabolic markers with overall safety language in secondary summaries. trial
- Blood pressure: Meta-analyses and hypertension trials (often ~1–6 g/day for weeks) report clinically discussed SBP/DBP reductions; effect sizes and populations vary (hypertensive vs mixed). trial
- Heart failure literature: Older double-blind work (e.g. multi-gram daily, sometimes ~2 g three times daily for short blocks) and later systematic reviews discuss improved cardiac-performance or capacity signals in CHF — medical context, not gym protocol. trial
- Metabolic / oxidative aging markers: Example human work includes ~1.5 g/day for 16 weeks in older women preserving SOD antioxidant-enzyme status vs placebo; glucose, lipids, and inflammation endpoints are mixed by study. trial
- Vegan / vegetarian status: Plasma and urinary taurine run lower without animal foods; healthy vegans are often not classically “deficient,” but longevity and performance threads still discuss optional multi-gram fill-in. trial
Doses people talk about
- Common longevity / general band: ~1–3 g/day oral in supplement and longevity threads (caps or powder). forum
- Science-paper human-equivalent talk: ~3–6 g/day is the most-cited translation of mid-life mouse arms into adult human oral discussion. forum
- Split-dosing discussion: BID or TID appears in discussion above ~2–3 g, including 1.5 g AM + 1.5 g PM or 2 g × 2–3. Posters cite GI comfort and a short plasma half-life as reasons; the plasma measurement does not establish a required dosing frequency. forum
- Longevity daily schedule: Fixed meal-paired grams (AM, or AM+PM) more common than training-only use among aging-stack users. forum
- Energy-drink exposure: Typical popular cans deliver ~1 g taurine per standard serving (e.g. classic Red Bull ~1000 mg / 250 mL class) plus caffeine; multi-can days stack caffeine risk more than pure taurine math. forum
- Capsule convenience: 500–1000 mg caps stacked to multi-gram totals; pill burden rises fast at 3–6 g. forum
- Lower-entry community habit: Some accounts describe beginning around 1 g, then increasing toward multi-gram amounts if GI tolerance allows. This preserves reported titration talk, not a recommended starting amount or escalation rule. forum
- Bulk powder math: Vendor scoops often ~0.9–2 g per labeled scoop/teaspoon fraction (e.g. ~1/4 tsp ≈ 0.9 g on some labels; ~3/4 tsp ≈ 2 g on others) — always weigh or trust the specific product facts panel. forum
- Dietary baseline: Usual omnivore food intake is often cited well under ~0.4 g/day; supplemental multi-gram bands sit far above diet alone. trial
- Broader human-trial band: Many performance, metabolic, and cardio trials cluster ~0.5–6 g/day total; designs may be single-dose or multi-week daily. trial
- Hypertension trial talk: Supplemental bands of ~3–6 g/day for ~1–8 weeks appear in clinical dosing summaries for BP research contexts. trial
- Heart-failure historical schedules: Multi-gram daily, including examples of ~2 g three times daily (~6 g/day) for short clinical blocks in older CHF literature. trial
- Upper clinical mentions: Highest commonly cited human trial dose ~10 g/day for up to ~6 months; longest cited trials extend toward ~12 months at lower ~0.5–1.5 g/day — not default consumer lore. trial
- Observed safe level (risk-assessment language): Shao & Hathcock-style observed safe level often quoted at ~3 g/day supplemental with higher confidence; higher doses appear in trials without a formal regulatory UL for all populations. trial
- Pre-workout timing: ~60 minutes before session is the most-repeated research-aligned timing; some write-ups use 30–90 minutes. trial
- Endurance multi-dose examples: Selected literature discusses higher total daily patterns (e.g. ~1 g five times daily) for muscle-damage contexts — not universal gym practice. trial
- Framing: Community, label, and literature discussion ranges only — research/education framing, not medical advice, prescriptions, or consumption guidance. forum
- Pre-workout acute (performance meta band): ~1–6 g single oral dose pre-exercise; community sweet-spot talk often ~1–2 g in DIY pre-workouts and label formulas. trial
How it may feel
- Day 1 acute pre-workout (1–3+ g, ~45–90 min pre): Often little stim-like buzz; any alertness usually blamed on stacked caffeine. forum
- Days 1–7 longevity-only daily: Most report no subjective “on” switch — systemic amino, not a stimulant. forum
- Days 1–7 multi-gram new users: GI fullness, loose stool, or mild nausea possible if boluses are large or on empty stomach. forum
- Week 1–2 training: Some claim fewer cramps, better dense sessions, or slightly better endurance feel; others null. forum
- Weeks 3–4 checkpoint: Longevity users usually still feel nothing and keep/stop on theory + cost; performance users keep if training markers improved. forum
- Month 1–3 background: Becomes a cheap daily powder habit alongside creatine/magnesium; sensation plateaus or never appears. forum
- Months 2–6+: Thin public “feel” diaries; people forget they take it unless they track BP, training, or labs. forum
- Energy-drink only users: Attribute jitters, focus, or crash to the can as a whole — cannot isolate taurine. forum
Cycles people discuss
- Default culture: Open-ended daily nutrient-style habit, not a short AAS-style blast/cruise. forum
- Training blocks: Some emphasize higher or more consistent grams during high-volume, heat, or contest-prep windows without formal off-cycles. forum
- Minority on/off lore: Occasional social posts invent 8-weeks-on / 4-weeks-off patterns; not a dominant evidence-based standard. anecdote
- Time off reasons: Cost, GI intolerance, stack simplification, or reaction to leukemia/biomarker headlines — not classic rebound fear. forum
- Restarts: Usually uneventful after a pause; no load protocol required. anecdote
- Clinical short blocks: CHF and BP trials often run weeks, not indefinite open label — different context than gym bulk powder. trial
- Longevity framing: Continuous mid-life-onward use is how the mouse story is told; human “years on multi-gram pure longevity” safety data remain thinner than marketing. trial
Timing
- Split-dose rationale in posts: Short plasma duration and GI comfort are cited for BID/TID at higher daily amounts. That explains the discussion, not an established need to match a supplement schedule to plasma elimination. forum
- Plasma half-life (oral PK study): After 4 g oral capsules fasting in healthy men, mean elimination t½ ~1.0 ± 0.3 h (reported range ~0.7–1.4 h). trial
- Tmax / Cmax: Mean Tmax ~1.5 ± 0.6 h (range ~1–2.5 h); mean Cmax ~86 mg/L (~0.69 mmol/L) in that 4 g design. trial
- Return toward baseline: Plasma concentrations fell back toward the normal range by roughly ~6.5 h post-dose in the same work (full curve followed over hours, not days). trial
- Why multi-gram daily still used: Community and research framing stress tissue pools, bile acids, and adaptive cellular effects more than holding a constant high plasma peak. forum
- Pre-workout alignment: ~60 min pre-session aims at the absorption/peak window from PK and performance write-ups. trial
- Downstream aging claims: Mouse lifespan/healthspan effects accrued over months of dosing — not an acute plasma spike story. animal
- Fed vs fasted: Consumer practice mixes meal-paired and fasted pre-workout use; formal PK above was fasting morning capsules. trial
More on what it is
- Why people care: Decades of sports-nutrition and cardio interest plus a 2023 Science mouse-lifespan paper that spiked longevity-forum demand; still often first met as “the thing in Red Bull.” forum
- Mechanism talk (forums/papers): Bile-acid conjugation, cell-volume/osmolyte balance, cardiac and skeletal-muscle calcium handling, antioxidant / mitochondrial-stress narratives, and GABA-adjacent calm claims (weaker). forum
- What it is: Conditionally essential sulfur-containing amino sulfonic acid (2-aminoethanesulfonic acid) made endogenously and eaten mainly in meat, seafood, and dairy; also a standard energy-drink and pre-workout label ingredient. Not a peptide, steroid, or proteinogenic amino acid. trial
- Evidence honesty: Human oral trials commonly use ~0.5–6 g/day across performance, BP, metabolic, and heart-failure endpoints; mouse mid-life supplementation extended average lifespan ~10–12% with multi-organ healthspan signals — definitive healthy-aging longevity RCTs in people remain incomplete. trial
- Biomarker pushback: 2025 longitudinal human/primate/mouse work concluded low circulating taurine is unlikely a good universal aging biomarker (levels often stable or rise with age and vary more by person than by age). trial
- Not this: Not a GH secretagogue, SARM, stimulant, or proven human “aging reverse” from rodent headlines alone. trial
Stacks
- Longevity box: Taurine + NMN or NR + magnesium ± creatine is a recurring “cheap aging stack” pattern after 2023. forum
- Creatine duo: Two high-evidence-or-high-discussion staples taken daily together for performance + general health narratives. forum
- Pre-workout classic: Taurine + caffeine (± citrulline, beta-alanine, tyrosine) — mirrors energy-drink logic with controllable doses. forum
- Cramp / electrolyte stack: Taurine + magnesium + potassium (sometimes sodium) for hard training, heat, or peak week. forum
- Magnesium taurate: Single product combining Mg with taurine; popular in sleep/heart threads — check elemental Mg and taurine contribution separately. forum
- Glycine evening pair: Multi-gram glycine for sleep + daytime or split taurine for longevity/performance in the same house stack. forum
- Ca-AKG / spermidine adjacency: Often listed beside other longevity staples rather than as a fixed ratio blend. forum
- NAC / antioxidant boxes: Discussed together for cellular-stress narratives; not a formal fixed-ratio protocol. forum
- Energy-drink real stack: Taurine + caffeine + sugar or sweeteners ± B-vitamins ± glucuronolactone — effects are multi-factor. forum
- What it is not stacked as: Not a peptide recon blend (not BPC/TB/GHK), not a SARM cycle partner by necessity. forum
Storage notes
- Oral forms and medical context: Consumer discussion centers on oral powder, capsules, foods and multi-ingredient drinks; the profile separately records IV use in medical literature. STUDresearch does not provide reconstitution, diluent-volume or syringe-unit charts. forum
- Storage (product-specific): Powders, capsules and drinks have different label requirements. General discussion keeps unopened products cool, dry and away from light; conditions after first use remain product-specific, not a universal forum SOP. forum
Watch for
- GI (most common): Nausea, stomach discomfort, bloating, loose stools, or diarrhea at higher multi-gram single boluses — main reason people split doses. forum
- Blood pressure / antihypertensives: Because trials can lower BP, community and clinical caution talk exists around additive effects with BP meds — formal interaction maps are limited. forum
- Energy-drink confound: Jitters, insomnia, tachycardia, and sugar crashes from cans are frequently misblamed on taurine when caffeine/sugar dominate. forum
- Source quality: Less exotic than gray peptides, but label accuracy, fill weight, and multi-ingredient pre-workout underdosing still vary. forum
- Neuro nonspecifics: Headache, dizziness, mild unsteadiness, or gait notes appear in higher-dose / sensitive-user reports and some clinical adverse-event lists. trial
- Other listed AEs: Nosebleed and miscellaneous mild symptoms show up in older clinical adverse notes at multi-gram intakes in some patient groups — uncommon in healthy gym logs. trial
- Bipolar / lithium caution: Neuromodulatory framing leads many safety summaries to urge clinician oversight in bipolar disorder or lithium use. forum
- Epilepsy / drug-metabolism talk: Caution language includes theoretical enzyme or drug-interaction concerns and adverse notes from some epilepsy-patient exposures (~1.5 g/day examples in secondary safety reviews). trial
- Kidney / severe organ disease: Special-population uncertainty; high-dose self-experimentation is widely discouraged without clinical supervision. trial
- Pregnancy / lactation / children: Maximum safe supplemental doses not well established; standard “clinician-first” caution in safety write-ups. trial
- Observed safe level tension: ~3 g/day is a commonly cited conservative observed safe supplemental level, while longevity and clinical literature often discuss 3–6 g (and occasional higher) — long multi-year healthy-user data at high grams remain thinner. trial
- Leukemia / bone-marrow model (2025 Nature-line coverage): Mouse/leukemia niche work suggests taurine can fuel glycolytic programs in certain leukemia contexts; authors and commentators urge caution about high-dose supplemental taurine in leukemia patients — not proof that normal dietary/supplement use “causes cancer” in healthy people. animal
- Older tumor-model noise: Mixed animal carcinogenicity literature (protective in some models, adverse signals in others) keeps human cancer risk unsettled rather than settled-safe or settled-harmful. animal
- Not risk-free: Short-trial tolerability ≠ unlimited lifetime high-dose proof; cheap and familiar is not the same as risk-free. trial
